Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 June 2023 | Story Katleho Leqheku | Photo Supplied
Katleho Leqheku
Katleho Leqheku is a Presidential Youth Employment Initiative (PYEI) Intern in the Health and Wellness Centre on the Bloemfontein Campus.

The University of the Free State (UFS) is celebrating Youth Month by showcasing the positive influence of the institution on career development. As part of this initiative, we are sharing the stories of UFS alumni who are now working at the university.

Katleho Leqheku, Presidential Youth Employment Initiative (PYEI) Intern in the Health and Wellness Centre on the Bloemfontein Campus, shares her UFS journey:

Q: Year of graduation from the UFS:

A: 2023.

Q: Qualification obtained from the UFS:

A: Bachelor of Arts in Psychology and Communication Science, currently doing my honours.

Q: Date of joining the UFS as a staff member:

A: April 2023.

Q: Initial job title and current job title:

A: PYEI intern in the Health and Wellness Centre on the Bloemfontein Campus.

Q: How did the UFS prepare you for the professional world?

A: The UFS has equipped me with in-depth knowledge. Through lectures, coursework, and research projects, I have gained a strong foundation of theoretical and practical knowledge related to what I am currently studying. Workshops offered by the UFS have been my key focus and an easy access to prep me for the professional world.

Q: What are your thoughts on transitioning from a UFS alumnus to a staff member?

A: Honestly, it’s an answered prayer because last year, while I was in my final year, I prayed for employment and to get accepted for honours. I consider the transition a worthwhile opportunity that allowed me to grow mentally as well as equipping myself with various skills. It’s not easy though, as I am used to being a full-time student with little pressure. But now the professional world requires a lot, like waking up early in the morning EVERY DAY! Lol, it’s a struggle and it requires one to show up each and every day whether you feel like it or not.

Q: Any additional comments about your experience?

A: It’s been good so far; I believe I am gradually allowing myself to grow and leave room for more opportunities to attract me. This experience is exactly what I needed so that I can learn and be comfortable with facing the world – not just any world, but a professional world. However, I thank God for this opportunity.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept